Explora I+D+i UPV

Volver atrás Publicación

The quantification of Epidermal Growth Factor Receptor (EGFR) in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients

Compartir
Año

CONGRESO

The quantification of Epidermal Growth Factor Receptor (EGFR) in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients